関連する実験動画
Updated: May 17, 2025

10:55
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
2.0K
標的型タンパク質安定化のためのデウビキチナーゼUSP1の活用
Chao Qian1, Zhen Wang2, Yan Xiong1
1Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.
Journal of the American Chemical Society
|April 19, 2025
まとめ
研究者らは USP1 を用いて新しいデウビキチナーゼ標的化キメラ (DUBTAC) 技術を開発し,がん治療の有望性を示した. これは標的型タンパク質の安定化のための DUBTAC 武器庫を拡張します.
科学分野:
- 生物化学
- 分子生物学
- 化学生物学
背景:
- デウビキチナーゼ標的化キメラ (DUBTAC) 技術は,標的型タンパク質安定化 (TPS) の新しいアプローチを提供します.
- 現在のDUBTAC開発は主にOTUB1とUSP7を使用しており,追加のデウビキチナゼ (DUB) の探査が必要である.
- USP1は様々なヒトの癌で頻繁に過剰発現し,治療戦略におけるその潜在的な関連性を示しています.
研究 の 目的:
- DUBTACの開発のためのデウビキチナゼとしてのUSP1の可能性を調査する.
- 標的型タンパク質の安定化のための新しいUSP1-リクルートDUBTACを設計する.
- これらのDUBTACの有効性をがんモデルで評価する.
主な方法:
- USP1の非共性小分子阻害剤を用いたUSP1を誘発するDUBTACの開発
- USP1ベースのCFTR DUBTAC (MS5310) とUSP1を採用するUTX DUBTAC (例えばMS7131) の生成
- タンパク質の安定化,標的の関与,がん細胞の増殖とクローン遺伝性に対する下流効果の評価.
主要な成果:
- MS5310は前回のDUBTACを上回る強力なCFTRの安定化を示した.
- MS7131は腫瘍抑制物質UTXを効果的に安定させ,オンコタンパク質JMJD3を保存した.
- MS7131によるUTX安定化により,H3K27のトリメチル化が減少し,がん細胞の増殖とクローン生成性が抑制された.
結論:
- USP1は,標的型タンパク質安定化のためのDUBTACの開発にうまく活用できます.
- MS7131は,UTXの独特な機能を研究するための貴重な化学ツールとして機能します.
- この研究は,DUBTACプラットフォームを拡張し,USP1とUTX不調に関連したがんに対する潜在的な治療戦略を提供します.
さらに関連する動画
関連する概念動画
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome
783
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
783
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
The Unfolded Protein Response
4.3K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.3K
The Proteasome Structure
661
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
661
Export of Misfolded Proteins out of the ER
3.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.4K

